Though still in trials, early results show tests may be more accurate than traditional clinical laboratory tests for detecting prostate cancer Within weeks of each other, different research teams in the US and UK published findings of their...

New artificial intelligence (AI) software that can help to spot prostate cancer is being trialled by researchers at Oxford University Hospitals (OUH) NHS Foundation Trust. Researchers and clinicians in Oxford have begun an evaluation of...

Ibex: NHS Expands Access to Ibex’s Galen™ Breast and Galen™ Prostate Solutions to 25 Trusts Across the UK Following PathLAKE Plus Consortium Bid Wins Tel Aviv, Israel – March 7, 2023 – Ibex Medical Analytics (Ibex), the leader...

Aiforia is happy to announce the win of this contract award, which enables us to offer our AI solutions directly for 25 NHS Trusts pathology departments in the UK. Aiforia has received a contract award to provide artificial intelligence...

Ibex: Pathology Diagnostics Platform Meets Safety, Quality and Performance Criteria Under EU's New In Vitro Diagnostic Medical Devices Regulation. TEL AVIV, Israel, Feb. 9, 2023 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in...

Deep Bio, a leading AI biotech dedicated to cancer diagnosis, and Visiopharm, a world leader in AI-powered image analysis and tissue mining for research and diagnostics, announced a strategic partnership to provide pathologists access to the...